Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Christopher Riedl

First-In-Human HER2-targeted Imaging Using89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients With Breast Cancer

Journal of Nuclear Medicine

English

Related publications

Molecular Imaging With Positron Emission Tomography and Computed Tomography (PET/CT) for Selecting First-Line Targeted Treatment in Metastatic Breast Cancer: A Cost-Effectiveness Study

Oncotarget

Oncology

2018

English

First-In-Human uPAR PET: Imaging of Cancer Aggressiveness

English

Estimated Life-Years Saved in Women With HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States

English

68Ga-Nota-Prgd2 PET/CT for Integrin Imaging in Patients With Lung Cancer

Journal of Nuclear Medicine

English

Pcn89 - Cost –Effectiveness Analysis of Pertuzumab as First Line Neoadjuvant Treatment Option for Patients Her2 + Breast Cancer in Republic of Macedonia

English

Quantitative Tumor Perfusion Imaging With 82Rubidium-Pet/Ct in Prostate Cancer – Analytical and Clinical Validation

Journal of Nuclear Medicine

English

Pharmacokinetic and Exploratory Exposure–response Analysis of Pertuzumab in Patients With Operable HER2-positive Early Breast Cancer in the APHINITY Study

Cancer Chemotherapy and Pharmacology

English

Patient With Metastatic Breast Cancer, HER2-positive, Trastuzumab- And Pertuzumab-Resistant Responding to Lapatinib

AboutOpen

2018

English

Pertuzumab in Human Epidermal Growth-Factor Receptor 2-Positive Breast Cancer: Clinical and Economic Considerations

International Journal of Women's Health

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Christopher Riedl

First-In-Human HER2-targeted Imaging Using89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients With Breast Cancer

Related publications

Molecular Imaging With Positron Emission Tomography and Computed Tomography (PET/CT) for Selecting First-Line Targeted Treatment in Metastatic Breast Cancer: A Cost-Effectiveness Study

First-In-Human uPAR PET: Imaging of Cancer Aggressiveness

Estimated Life-Years Saved in Women With HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States

68Ga-Nota-Prgd2 PET/CT for Integrin Imaging in Patients With Lung Cancer

Pcn89 - Cost –Effectiveness Analysis of Pertuzumab as First Line Neoadjuvant Treatment Option for Patients Her2 + Breast Cancer in Republic of Macedonia

Quantitative Tumor Perfusion Imaging With 82Rubidium-Pet/Ct in Prostate Cancer – Analytical and Clinical Validation

Pharmacokinetic and Exploratory Exposure–response Analysis of Pertuzumab in Patients With Operable HER2-positive Early Breast Cancer in the APHINITY Study

Patient With Metastatic Breast Cancer, HER2-positive, Trastuzumab- And Pertuzumab-Resistant Responding to Lapatinib

Pertuzumab in Human Epidermal Growth-Factor Receptor 2-Positive Breast Cancer: Clinical and Economic Considerations